Day: March 2, 2021

SALINAS, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: INDS converting to LOWL; OTCQX: INDXF to LOWLF effective March 5, 2021), a leading, vertically-integrated, California-focused cannabis company, announced revenue and operating results for the fourth quarter and fiscal year (ended December 31, 2020). All figures stated are in US Dollars.Fourth Quarter and Fiscal Year Financial Highlights:Revenue generated for the three-month period ended December 31, 2020, was $9.2 million; a decline of 15% from the fourth quarter last year. Revenue for the year ended December 31, 2020, was $42.6 million; 15% year-over-year growth.Adjusted EBITDA for the three-month period ended December 31, 2020, was ($3.7 million) compared to ($13.2 million) in the fourth quarter last year; Adjusted EBITDA for the year-end...

SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference. The conference is being held on March 9-10, 2021 virtually.Keith Murphy, Executive Chairman of Organovo, will provide an overview of the Company’s business during the presentation.A webcast of Organovo’s presentation will be accessible through the Investors & Media section of the company’s website at www.organovo.com. A replay of the webcast will be available on Organovo’s website for 90 days following the conference.About OrganovoOrganovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug...

SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.The presentation will be available on-demand beginning on Tuesday, March 9, 2021, in the Investors section on the Company’s website at www.traconpharma.com.About TRACONTRACON develops targeted therapies for cancer utilizing a capital efficient,...

BEVERLY, Mass., March 02, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, announced today that the Company has received approximately $3.6M CAD ($2.9M USD) in warrant exercises since the start of 2021.Dr. Jack Regan, LexaGene’s CEO and Founder states, “Achieving our first commercial sales in combination with a very positive outlook for 2021 has resulted in the appreciation of our share price over the last few months. The receipt of exercised warrants has significantly added to our treasury and puts us in a strong financial position for 2021.”The COVID-19 pandemic has presented significant challenges for sales travel and demonstrations, as many hospitals, clinics and businesses are not allowing...

TORONTO, March 02, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (“WeedMD” or the “Company”) (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, announced today that, further to its press release dated February 11, 2021 announcing a $17.5 million bought deal financing (the “Offering”), the Company has entered into an amended and restated underwriting agreement dated March 2, 2021, with Eight Capital and Canaccord Genuity Corp., as joint bookrunners and co-lead underwriters (the “Co-Lead Underwriters”), and INFOR Financial Inc. (together with the Co-Lead Underwriters, the “Underwriters”) to amend the terms of the Offering to issue to the Underwriters 31,250,000 units of the Company (the “Units”) at a price per Unit of $0.48 (the “Issue Price”) for gross proceeds of $15,000,000. Each...

To Nasdaq OMX Copenhagen02 March 2021Company announcement no. 03/2021Notice of annual general meeting 2021The BANK of Greenland A/S will hold its annual general meeting on Wednesday 24 March 2021 at 4pm (WGT) at the BANK of Greenland’s head office in Nuuk.The agenda is included in the attached file.Anni Søe Svendsen, tel. +299 347802, mail: shareholder@banken.glAttachment03.Indkaldelse_2021_ENG

Til Nasdaq OMX Copenhagen02. marts 2021Selskabsmeddelelse nr. 03/2021Indkaldelse til ordinær generalforsamling 2021GrønlandsBANKEN A/S afholder ordinær generalforsamling onsdag den 24. marts 2021 kl. 16.00 (WGT) i GrønlandsBANKENs hovedkontor i Nuuk.Dagsordenen kan ses i den vedhæftede fil.Kontakt: Anni Søe Svendsen, telefon: +299 347802, mail: aktionaer@banken.glVedhæftet fil03.Indkaldelse_2021_DK